Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ronen

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Neuro-Oncology|June 7, 2012
Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 teslaMyriam M Chaumeil, Beatrice Gini, Huijun Yang, et al.
Epilepsy & Behavior : E&B|April 3, 2019
Can behavioral strategies increase physical activity and influence depressive symptoms and quality of life among children with epilepsy? Results of a randomized controlled trialDenver M Y Brown, Nadilein Mahlberg, Daniela Pohl, et al.
Journal of the National Cancer Institute|November 6, 2003
Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer modelsYuen-Li Chung, Helen Troy, Udai Banerji, et al.
Nature Communications|September 11, 2013
Non-invasive in vivo assessment of IDH1 mutational status in gliomaMyriam M Chaumeil, Peder E Z Larson, Hikari A I Yoshihara, et al.
Seizure|May 21, 2021
Cognitive outcome in children with infantile spasms using a standardized treatment protocol. A five-year longitudinal studyJonathan Y Bitton, Béatrice Desnous, Hannelore C Sauerwein, et al.
Cancer Research|September 22, 2020
Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide TreatmentElavarasan Subramani, Marina Radoul, Chloe Najac, et al.
Magnetic Resonance in Medicine|August 2, 2012
Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imagingIlwoo Park, Simon Hu, Robert Bok, et al.
British Journal of Cancer|June 11, 1999
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosisS M Ronen, F DiStefano, C L McCoy, et al.
Neuro-Oncology|December 25, 2013
Lactate dehydrogenase A silencing in IDH mutant gliomasCharles Chesnelong, Myriam M Chaumeil, Michael D Blough, et al.
NMR in Biomedicine|December 22, 1998
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatmentM O Leach, M Verrill, J Glaholm, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Neuro-Oncology|June 7, 2012
Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 teslaMyriam M Chaumeil, Beatrice Gini, Huijun Yang, et al.
Epilepsy & Behavior : E&B|April 3, 2019
Can behavioral strategies increase physical activity and influence depressive symptoms and quality of life among children with epilepsy? Results of a randomized controlled trialDenver M Y Brown, Nadilein Mahlberg, Daniela Pohl, et al.
Journal of the National Cancer Institute|November 6, 2003
Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer modelsYuen-Li Chung, Helen Troy, Udai Banerji, et al.
Nature Communications|September 11, 2013
Non-invasive in vivo assessment of IDH1 mutational status in gliomaMyriam M Chaumeil, Peder E Z Larson, Hikari A I Yoshihara, et al.
Seizure|May 21, 2021
Cognitive outcome in children with infantile spasms using a standardized treatment protocol. A five-year longitudinal studyJonathan Y Bitton, Béatrice Desnous, Hannelore C Sauerwein, et al.
Cancer Research|September 22, 2020
Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide TreatmentElavarasan Subramani, Marina Radoul, Chloe Najac, et al.
Magnetic Resonance in Medicine|August 2, 2012
Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imagingIlwoo Park, Simon Hu, Robert Bok, et al.
British Journal of Cancer|June 11, 1999
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosisS M Ronen, F DiStefano, C L McCoy, et al.
Neuro-Oncology|December 25, 2013
Lactate dehydrogenase A silencing in IDH mutant gliomasCharles Chesnelong, Myriam M Chaumeil, Michael D Blough, et al.
NMR in Biomedicine|December 22, 1998
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatmentM O Leach, M Verrill, J Glaholm, et al.
Pageof 22